Table 3.
Test | Age, y | N | Mean (μ) | Number of positive (%) | OR (95% CI) | Force of infection |
---|---|---|---|---|---|---|
TST≥5 mm | <6 | 74 | 3.2 | 25 (34) | 0.51 (0.32 to 0.83) | 0.049 |
6–14 | 177 | 10.0 | 78 (44) | 0.79 (0.59 to 1.06) | 0.192 | |
15–18 | 77 | 16.4 | 41 (53) | 1.14 (0.73 to 1.78) | 0.328 | |
19–45 | 510 | 31.9 | 291 (57) | 1.33 (1.12 to 1.58) | 0.216 | |
>45 | 139 | 54.9 | 94 (68) | 2.09 (1.46 to 2.98) | 0.138 | |
Total | 977 | 27.8 | 529 (54) | 0.158 | ||
p-value | 0.050 | |||||
QFT-GIT | <6 | 72 | 3.2 | 25 (35) | 0.53 (0.33 to 0.86) | 0.442 |
6–14 | 164 | 10.0 | 62 (38) | 0.61 (0.44 to 0.83) | 0.360 | |
15–18 | 78 | 16.4 | 46 (59) | 1.44 (0.92 to 2.26) | 0.806 | |
19–45 | 497 | 31.9 | 286 (58) | 1.36 (1.13 to 1.62) | 0.483 | |
>45 | 134 | 54.9 | 92 (69) | 2.19 (1.52 to 3.16) | 1.094 | |
Total | 945 | 27.8 | 511 (54) | 0.571 | ||
p-value | 0.059 | |||||
LTBI | <6 | 80 | 3.2 | 38 (48) | 0.90 (0.58 to 1.40) | 0.438 |
6–14 | 182 | 10.0 | 97 (53) | 1.14 (0.85 to 1.53) | 0.363 | |
15–18 | 79 | 16.4 | 61 (77) | 3.39 (2.00 to 5.73) | 0.696 | |
19–45 | 525 | 31.9 | 408 (78) | 3.49 (2.84 to 4.28) | 1.153 | |
>45 | 142 | 54.9 | 121 (85) | 5.76 (3.63 to 9.16) | 1.254 | |
Total | 1008 | 27.8 | 725 (72) | 0.820 | ||
p-value | 0.052 |
Force of infection: calculated at specific ages for the pool of individuals who remained uninfected (absolute change in prevalence/[1-baseline prevalence]); LTBI, latent TB infection; N, total participants; OR was calculated by considering all other subgroups as reference; QFT-GIT, Quantiferon-Gold In tube test; TST, tuberculin skin test.